Related Experiment Video

Updated: May 22, 2026

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

Peptide vaccine

Shuichi Izumoto1

  • 1Department of Neurosurgery, Hyogo College of Medicine, Hyogo, Japan. sizumoto@hyo-med.ac.jp

Advances in Experimental Medicine and Biology
|May 29, 2012
PubMed

Insights

Malignant glioma patients may benefit from peptide-based vaccination, a promising cancer immunotherapy. This approach primes the immune system to fight glioma cells, potentially improving survival without significant side effects.

Area of Science:

  • Oncology
  • Immunology
  • Neuro-oncology

Background:

  • Malignant gliomas have poor prognoses despite current treatments like surgery, radiation, and chemotherapy.
  • Novel therapeutic strategies are urgently needed to improve long-term survival rates.
  • Cancer immunotherapy offers a new avenue by harnessing the patient's immune system against cancer cells.

Purpose of the Study:

  • To review the clinical progress of peptide-based vaccinations for malignant glioma.
  • To evaluate the potential of peptide vaccines in inducing anti-glioma immune responses.
  • To assess the efficacy and safety of peptide vaccination in malignant glioma patients.

Main Methods:

  • Review of clinical studies and trials involving peptide-based vaccines for malignant glioma.
  • Analysis of data on immune response induction, clinical outcomes, and side effects.
  • Assessment of the current status and future directions of this therapeutic strategy.

Main Results:

  • Peptide-based vaccination shows promise in inducing antineoplastic immune responses against malignant glioma.
  • Early clinical data suggest potential for clinical response and prolonged survival.
  • This immunotherapy approach appears to have a favorable safety profile with minimal side effects.

Conclusions:

  • Peptide-based vaccination is a promising immunotherapy strategy for malignant glioma.
  • Further clinical development is warranted to establish its role in improving patient survival.
  • This approach represents a potential advancement in treating malignant glioma.

More Related Videos

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Related Concept Videos

Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccinations01:51

Vaccinations

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cross-reactivity00:42

Cross-reactivity

Overview
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Peptide Identification Using Tandem Mass Spectrometry01:33

Peptide Identification Using Tandem Mass Spectrometry

Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...